1、Hu J*, Liu YF, Wu CF, Xu F, Shen ZX, Zhu YM, Li JM, Tang W, Zhao WL, Wu W, Sun HP, Chen QS, Chen B, Zhou GB, Zelent A, Waxman S, Wang ZY, Chen SJ, Chen Z. Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia.. PNAS,2009;106：3342-47
2、Hu J*, Zhou GB, Wang ZY, Chen SJ, Chen Z. Mutant transcription factors and tyrosine kinases as therapeutic targets for leukemias: from acute promyelocytic leukemia to chronic myeloid leukemia and beyond.. Adv Cancer Res.,2007;98:191-220
3、Zhu YM, Liu YF, Zhang SJ, Shen ZX, Hu J.#. FLT3 internal tandem duplication in patients with acute promyelocytic leukemia]. Zhonghua Xue Ye Xue Za Zhi,2007;28(6):371-4
4、Hu J*, Fang J, Dong Y, Chen SJ, Chen Z.. Arsenic in cancer therapy.. Anticancer Drugs,2005;16(2):119-27
|
